Overview

Novo Holdings A/S is a private limited liability company wholly owned by the Novo Nordisk Foundation. The company focuses on managing the funds of the Novo Nordisk Foundation and provides seed and venture capital to life science companies. It holds significant securities in Novo Nordisk A/S and Novozymes A/S.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Novo Holdings A/S in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.